About Enhancer
| Enhancer ID: | E_03378 |
| Species: | Homo sapiens |
| Position : | chr11:17710000-17711000   |
| Year: | 2022 |
| Title: | Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer-promoter interactions. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cervical cancer |
| PMID: | 35849129 |
| MONDO: | MONDO:0002974 |
| Tissue: | uterine cervix |
| Tissue Ontology ID: | UBERON:0000002 |
| Cell Source: | HeLa |
| CVCL ID: | CVCL_0030 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Functional perturbation assay |
| Low Throughput Method: | CRISPR Knockout; CRISPRi; RT-RT-qPCR |
About Target Gene
| Target gene : | MYOD1 |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Expression of Target Genes for the Enhancer